absolute neutrophil count; ANC; acute leukemia; ALL; alloSCT; AML; adverse event management; AE; AUGMENT 101; AUGMENT-101; black box; differentiation syndrome; DS; dose; efficacy; exposure response; HSCT; inducer; inhibitor; interaction; interactions; KMT2A; KMT2Ar; KMT2At; lymphoblastic; management; mechanism; mixed phenotype; mixed-phenotype; MOA; monotherapy; MPAL; pediatric; peds; pharmacokinetics; pk; prescribing information; QT; QTC; rearranged; refractory; relapsed; Revuforj; translocated; transplant; safety; stability; storage; npm1; npm1m; peds; pediatric; pediatrics